CyberKnife for prostate cancer in China typically costs from Price on request to Price on request . The final price depends on the city, hospital accreditation, and the number of treatment sessions. In the United States, patients can expect to pay around $55,000 on average. China offers significant savings of approximately 69%. Standard packages often include consultations, medical planning, and local transfers.
Bookimed Expert Insight: Choosing a tertiary Class-III hospital provides high-volume expertise at a competitive price. Jinshazhou Hospital of Guangzhou University of Chinese Medicine treats over 680,000 patients annually. Their CyberKnife M6 packages start around $8,200 and include doctor consultations and medications. This setup ensures patients receive university-level care and OECI-accredited standards without paying premium international clinic rates.
| China | Turkey | Austria | |
| CyberKnife for prostate cancer | from $10,500 | from $25,000 | from $25,000 |
No hidden fees – just official clinic prices. Pay at the clinic for CyberKnife for prostate cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in CyberKnife for prostate cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your CyberKnife for prostate cancer journey.
Day 1: Arrival
Day 2: Pre-Operation
Day 3: Rest Day
Day 4: CyberKnife Treatment
Day 5: Post-Treatment
Day 6: Discharge
Week 1-2: Rehabilitation
Week 3-4: Return to Work
Please note that the above timeline is a general guideline and individual experiences might vary based on specific clinical situations. Always consult with your healthcare professional for personalized advice.
CyberKnife for prostate cancer is a non-invasive treatment utilizing precision radiation therapy to target and treat prostate tumors.